Customize your JAMA Network experience by selecting one or more topics from the list below.
Ambrose SE, Ongkasuwan J, Dedhia K, et al. Analysis of Vocal Fold Motion Impairment in Neonates Undergoing Congenital Heart Surgery. JAMA Otolaryngol Head Neck Surg. 2018;144(5):406–412. doi:10.1001/jamaoto.2017.3459
Do differences in cost, postprocedure length of stay (PPLOS), and outcomes for neonates with and without vocal fold motion impairment (VFMI) after congenital heart surgery exist?
In this cross-sectional analysis of 3725 neonates, the proportion diagnosed with VFMI after congenital heart surgery was 6.9%. Neonates diagnosed with VFMI had significantly higher total hospital cost and PPLOS compared with those who did not; there were no differences in odds of pneumonia, gastrostomy, or tracheostomy.
Vocal fold motion impairment following congenital heart surgery was associated with increased cost and PPLOS, and protocols for early identification of VFMI or techniques to prevent VFMI may result in a decrease in cost and PPLOS.
Vocal fold motion impairment (VFMI) is a known risk factor following congenital heart surgery (CHS). The impact of this diagnosis on utilization and outcomes is unknown.
To evaluate the cost, postprocedure length of stay (PPLOS), and outcomes for neonates with VFMI after CHS.
Design, Setting, and Participants
A cross-sectional analysis of the 2012 Kids’ Inpatient Database (KID) of neonates who underwent CHS was carried out. The KID is an administrative data set of patients, aged 20 years or younger, and contains data on more than 10 million hospitalizations from 44 states. The KID is limited to inpatient hospitalization and contains discharge summary level of data. Patients were limited to those who were born during the hospitalization and those who were aged 28 days or younger at the time of admission for CHS. A weighted total of 4139 neonates who underwent CHS were identified, of which 3725 survived. The proportion of neonates diagnosed with VFMI was 264 (6.92%) of 3725.
Congenital heart surgery.
Main Outcomes and Measures
Cost of inpatient hospital stay, postprocedure length of stay, odds of pneumonia, gastrostomy tube placement, and tracheostomy tube placement. Risk-adjusted generalized linear models examined differences in cost and PPLOS between neonates who underwent CHS and were diagnosed with VFMI and those who were not. Risk-adjusted logistic regression compared the odds of selected outcomes (gastrostomy, tracheostomy, pneumonia). Models were weighted to provide national estimates.
Of 3725 neonates (aged 0-28 days), 2203 (59.1%) were male and 1517 (40.7%) were female. Neonates diagnosed with VFMI had significantly higher total cost by $34 000 (95% CI, 2200-65 000) and PPLOS by 9.1 days (95% CI, 4.6-13.7) compared with those who did not. When PPLOS was included as a covariate in the model for cost, presence of VFMI was no longer significant. There were no differences in odds of pneumonia, gastrostomy, or tracheostomy.
Conclusions and Relevance
Vocal fold motion impairment after CHS was associated with significant increases in cost owing to increased PPLOS. These findings provide a foundation to further investigate standardized screening for VFMI following CHS; early identification and treatment may decrease cost and PPLOS.
Create a personal account or sign in to: